Heparin Market Size & Share to Record New Values for the Forecast Period 2020-2030
July 2021
172
About the Report
About the Report
Market Overview
Heparin, commonly known as unfractionated heparin (UFH), is a naturally occurring glycosaminoglycan. It is used in medicine as an anticoagulant (blood thinner). It is very beneficial in the treatment of heart attacks and angina pectoris. It's injected either into a vein or under the skin. Acute coronary syndrome, deep vein thrombosis, pulmonary embolism, and atrial fibrillation, as well as cardiopulmonary bypass and hemofiltration during heart surgery, are all treated with it. It can also be used to provide major orthopedic surgeries like hip and knee replacements. The COVID-19 pandemic has caused chaos on health-care workflows all around the world. A huge number of individuals are suffering from coronavirus, which is associated to respiratory disorders, during the COVID-19 pandemic. As a result, the demand for heparin has risen, as it aids in the management of pulmonary inflation and the thinning of the blood of people at risk of a blood clot.
Heparin Market: Key Players
- Baxter International Inc.
Company Overview, Business Strategy, Key Product Offerings, Financial Performance, Key Performance Indicators, Risk Analysis, Recent Development, Regional Presence, SWOT Analysis
- B. Braun Holding GmbH & Co. KG
- Dr. Reddy’s Laboratories Ltd.
- Fresenius SE & Co KGaA
- Hebei Changshan Biochemical Pharmaceutical Co. Ltd.
- Leo Pharma A/S
- Pfizer Inc.
- Sanofi S.A
- Teva Pharmaceuticals
- Viatris Inc.
Growth Factor
Rising Incidence of Chronic Disorders to Incite market growth
The rising global prevalence of cardiovascular disorders, such as heart attacks and strokes, will provide market possibilities. According to the American Heart Association's (AHA) Heart Disease and Stroke Statistics, atrial fibrillation affected 5.3 million Americans in 2019. The rising patient demand for heparin might have a significant influence on the market.
Segmentation
- By Product
- Unfractionated Heparin
- Low Molecular Weight Heparin (LMWH)
- Ultra-low Molecular Weight Heparin (ULMWH)
- By Application
- Venous Thromboembolism
- Coronary Artery Disease
- Atrial Fibrillation
- Others
- By Distribution Channel
- Hospital Pharmacies
- Drug Stores & Retail Pharmacies
- Online Pharmacies
- Heparin market Dynamics
- Heparin market Size
- Supply & Demand
- Current Trends/Issues/Challenges
- Competition & Companies Involved in the Market
- Value Chain of the Market
- Market Drivers and Restraints
Recent News Related to Market
-
In December 2020, Valeo Pharma Inc. gained approval from Health Canada for its low molecular weight heparin 'Redesca and Redesca HP'.
-
In May 2020, The University of Manitoba launched a research research to see if heparin, a blood-thinning medicine, can be used to treat COVID-19 patients. The clinical experiment took place in 35 different locations across Canada, the United States, Mexico, and Brazil.
The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:
- COVID-19 pre and post business impact analysis
- Detailed overview of the parent market
- Changing market dynamics in the industry
- In-depth market segmentation
- What is the Heparin market growth?
- Which segment accounted for the largest Heparin market share?
- Who are the key players in the Heparin market?
- Historical, current and projected market size in terms of volume and value
- Recent industry trends and developments
- Competitive landscape
- Strategies of key players and products offered
- Potential and niche segments, geographical regions exhibiting promising growth
- A neutral perspective on market performance
- Must-have information for market players to sustain and enhance their market footprint
Note: Although care has been taken to maintain the highest levels of accuracy in Fatpos Global’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.
Products
Table of Contents
Table of Contents
Contents
- Executive Summary
- Global Heparin Market
- Product Overview
- Market Definition
- Segmentation
- Assumptions and Acronyms
- Research Methodology
- Research Objectives
- Primary Research
- Secondary Research
- Forecast Model
- Market Size Estimation
- Average Pricing Analysis
- Macro-Economic Indicators
- Market Dynamics
- Growth Drivers
- Restraints
- Opportunity
- Trends
- Correlation & Regression Analysis
- Correlation Matrix
- Regression Matrix
- Recent Development, Policies & Regulatory Landscape
- Risk Analysis
- Demand Risk Analysis
- Supply Risk Analysis
- Global Heparin Market Analysis
- Porters Five Forces
- Threat of New Entrants
- Bargaining Power of Suppliers
- Threat of Substitutes
- Rivalry
- PEST Analysis
- Political
- Economic
- Social
- Technological
- Porters Five Forces
- Global Heparin Market
- Market Size & forecast, 2020A-2030F
- By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
- By Volume (Million Units) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
- Market Size & forecast, 2020A-2030F
- Global Heparin Market: Market Segmentation
- By Regions
- North America:(U.S., Mexico and Canada), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
- Europe: (Germany, UK, France, Italy, Spain, Russia and Rest of Europe), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
- Asia-Pacific: (China, India, Japan, Australia and Rest of Asia Pacific), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
- LAMEA: (Brazil, Saudi Arabia, South Africa, Rest of LAMEA), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
- By Product: Market Share (2020-2030F)
- Unfractionated Heparin, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
- Low Molecular Weight Heparin (LMWH), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
- Ultra-low Molecular Weight Heparin (ULMWH), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
- By Application: Market Share (2020-2030F)
- Venous Thromboembolism, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
- Coronary Artery Disease, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
- Atrial Fibrillation, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
- Others, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
- By Distribution channel: Market Share (2020-2030F)
- Hospital Pharmacies, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
- Drug Stores & Retail Pharmacies, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
- Online Pharmacies, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
- By Regions
Company Profile
- Baxter International Inc.
- Company Overview
- Company Total Revenue (Financials)
- Market Potential
- Global Presence
- Key Performance Indicators
- SWOT Analysis
- Product Launch
- B. Braun Holding GmbH & Co. KG
- Dr. Reddy’s Laboratories Ltd.
- Fresenius SE & Co KGaA
- Hebei Changshan Biochemical Pharmaceutical Co. Ltd.
- Leo Pharma A/S
- Pfizer Inc.
- Sanofi S.A
- Viatris Inc.
- Teva Pharmaceuticals
Consultant Recommendation
**The above-given segmentations and companies could be subjected to further modification based on in-depth feasibility studies conducted for the final deliverable.
Why Buy From US?
What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story
We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.
While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.
With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.
Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.
If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.